Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1969 1
1970 1
1971 1
1973 1
1977 1
1979 1
1998 1
1999 1
2005 1
2006 1
2007 2
2010 1
2011 2
2013 3
2014 7
2015 9
2016 8
2017 7
2018 12
2019 11
2020 5
2021 14
2022 17
2023 17
2024 27
2025 32
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Kuchanskyi
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2025 May;15(2_suppl):793S-822S. doi: 10.1177/21925682251336882. Epub 2025 May 21. Global Spine J. 2025. PMID: 40397527 Free PMC article. No abstract available.
Corrigendum.
[No authors listed] [No authors listed] J Cereb Blood Flow Metab. 2016 Aug;36(8):1477. doi: 10.1177/0271678X16652376. J Cereb Blood Flow Metab. 2016. PMID: 27480270 Free PMC article.
Interleukin-1beta transfer across the blood-brain barrier in the ovine fetusGrazyna B Sadowska, Xiaodi Chen, Jiyong Zhang, Yow-Pin Lim, Erin E Cummings, Oleksandr Makeyev, Walter G Besio, John Gaitanis, James F Padbury, William A Banks and Barbara S StonestreetJournal of C …
Interleukin-1beta transfer across the blood-brain barrier in the ovine fetusGrazyna B Sadowska, Xiaodi Chen, Jiyong Zhang, Yow-Pin Lim, Erin …
Metal-free photoanodes for C-H functionalization.
Zhang J, Zhu Y, Njel C, Liu Y, Dallabernardina P, Stevens MM, Seeberger PH, Savateev O, Loeffler FF. Zhang J, et al. Nat Commun. 2023 Nov 4;14(1):7104. doi: 10.1038/s41467-023-42851-w. Nat Commun. 2023. PMID: 37925550 Free PMC article.
First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study.
Dudnichenko O, Penkov K, McKean M, Mandalà M, Kukushkina M, Panella T, Csőszi T, Gerletti P, Thakur M, Polli A, di Pietro A, Schadendorf D. Dudnichenko O, et al. Eur J Cancer. 2024 Dec;213:115070. doi: 10.1016/j.ejca.2024.115070. Epub 2024 Oct 11. Eur J Cancer. 2024. Update in: Future Oncol. 2025 May;21(12):1445-1455. doi: 10.1080/14796694.2025.2488226. PMID: 39427441 Free article. Updated. Clinical Trial.
Saturated Boronic Acids, Boronates, and Trifluoroborates: An Update on Their Synthetic and Medicinal Chemistry.
Volochnyuk DM, Gorlova AO, Grygorenko OO. Volochnyuk DM, et al. Chemistry. 2021 Nov 5;27(62):15276. doi: 10.1002/chem.202103751. Epub 2021 Oct 28. Chemistry. 2021. PMID: 34709677
Invited for the cover of this issue are Oleksandr Grygorenko and co-workers at Enamine Ltd., Institute of Organic Chemistry NAS Ukraine, and Taras Shevchenko National University of Kyiv. ...
Invited for the cover of this issue are Oleksandr Grygorenko and co-workers at Enamine Ltd., Institute of Organic Chemistry NAS Ukrai …
175 results